UCLA researchers study cost-effectiveness of rectal cancer treatments
“As our treatments become more technical and expensive, it is our responsibility to prove that these treatments lead to benefits that warrant the increased cost,” said UCLA’s Dr. Ann Raldow, the study's first author.